Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Photogen to Focus on Cardiovascular Imaging
Aug 2002
NEW HOPE, Pa., Aug. 13 -- Photogen Technologies Inc. announced it will use $16.25 million in new equity capital to implement its restructuring plan, which will focus the company's resources on cardiovascular imaging and lymphography.

Photogen has agreed to split off its photodynamic therapy and laser device business to five founding shareholders in exchange for all their common stock, which represents 52.9 percent of the company's outstanding shares. Photogen will focus its resources on developing PH-50, a cardiovascular imaging agent designed to improve images of the heart and vasculature obtained with computed tomography (CT) machines and N-1177 for use in lymphography.

The company has also signed a financing agreement to sell $16.25 million of common stock to a group of venture capital funds led by Mi3 LP of Wellesley, Mass., and including Oxford Biosciences and New England Partners.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.